High prevalence and negative impact of sarcopenia on oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

MLA

G. Califano, et al. “High Prevalence and Negative Impact of Sarcopenia on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.” European Urology Open Science, vol. 20, no. 161–162, Oct. 2020, pp. S161–62. EBSCOhost, https://doi.org/10.1016/S2666-1683(20)35600-7.

APA

G. Califano, C.Collà Ruvolo, R. La Rocca, L. Napolitano, M. Capece, M. Creta, G. Celentano, F. Crocetto, F. Mangiapia, A. Palmieri, N. Longo, P. Verze, C. Imbimbo, V. Mirone, S.F. Shariat, & E. Xylinas. (2020). High prevalence and negative impact of sarcopenia on oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. European Urology Open Science, 20(161–162), S161–S162. https://doi.org/10.1016/S2666-1683(20)35600-7

Chicago

G. Califano, C.Collà Ruvolo, R. La Rocca, L. Napolitano, M. Capece, M. Creta, G. Celentano, et al. 2020. “High Prevalence and Negative Impact of Sarcopenia on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.” European Urology Open Science 20 (161–162): S161–62. doi:10.1016/S2666-1683(20)35600-7.